Thomas Seufferlein

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Michel Ducreux, Caroline Caramella, Antoine Hollebecque et al. · Annals of Oncology · 2015 · 1.3K citations · Full text

Medicine, Oncology, Surgery +12

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

Janis A. Müller, Rüdiger Groß, Carina Conzelmann et al. · Nature Metabolism · 2021 · 567 citations · Full text

Life Sciences, Endocrinology, Infectious Diseases +17

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Thierry Conroy, Per Pfeiffer, Valérie Vilgrain et al. · Annals of Oncology · 2023 · 511 citations · Full text

Medicine, Oncology, Surgery +14